1-((3-Bromo-4-methylphenyl)sulfonyl)piperidine, 95.0%, 5g

1-(3-Chloropropyl)piperidine Hydrochloride>98.0%(T)5g

methyl 2-amino-5,5,7,7-tetramethyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate, 95.0%, 500mg

1-(2-methylphenyl)-2,3-dihydro-1H-imidazole-2-thione, 97%, 100mg

4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 25g

Potassium (S)-2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate, 95.0%, 5g

4-Methyl-1,2,3,4-tetrahydroquinoline, 95.0%, 1g

Ethyl 3-(pyridin-2-yl)propanoate, 95.0%, 10g

Ethyl 3-oxo-3-(3-pyridyl)propionate, 95.0%, 10g

7-Bromo-2-(4-hydroxyphenyl)benzo[d]oxazol-5-ol, 97.0%, 100mg

Flat flange reaction vial DURAN®, DN 100, 1000 ml, 138 mm, 106 mm, Height, 205 mm, 1 Piece

Biphenyl-4-carboxylic Acid>98.0%(GC)(T)25g

N-(2-amino-4-methylphenyl)propanamide, 95.0%, 5g